A Powerful Platform for Stem Cell Research and Drug Discovery

9 May 2018

George Kosmidis, scientist at Ncardia, is involved in the fascinating field of stem cell biology; specifically the use of stem cell derived cardiomyocytes as a platform for drug efficacy and toxicity screening. In this video, Kosmidis describes how the CLARIOstar® is integral to his research. Using this advanced monochromator microplate reader he is able to analyse DNA damage, mitochondrial content and ROS species. He also explains how the powerful software analysis platform truly sets the CLARIOstar apart.